These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7887392)

  • 1. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels.
    Sacks FM; Rouleau JL; Moye LA; Pfeffer MA; Warnica JW; Arnold JM; Nash DT; Brown LE; Sestier F; Rutherford J
    Am J Cardiol; 1995 Mar; 75(8):621-3. PubMed ID: 7887392
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
    Gambhir DS
    Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL; Carek PJ
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy and clinical trials.
    Elkeles RS
    Curr Opin Lipidol; 1998 Feb; 9(1):77-9. PubMed ID: 9502341
    [No Abstract]   [Full Text] [Related]  

  • 8. [CARE[ Cholesterol and Recurrent Events Trial]].
    Oida K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():427-32. PubMed ID: 11347108
    [No Abstract]   [Full Text] [Related]  

  • 9. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 10. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.
    Pfeffer MA; Sacks FM; Moyé LA; Brown L; Rouleau JL; Hartley LH; Rouleau J; Grimm R; Sestier F; Wickemeyer W
    Am J Cardiol; 1995 Sep; 76(9):98C-106C. PubMed ID: 7572695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less heat, more light.
    Rees A
    Curr Opin Lipidol; 1999 Jun; 10(3):219-23. PubMed ID: 10431658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol reduction and coronary artery disease. An overview of clinical trials up to 1986.
    Tikkanen MJ; Pyörälä K
    Drugs; 1988; 36 Suppl 3():27-31. PubMed ID: 3076117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 17. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 2. Implications for heart disease prevention in Australia.
    Silberberg JS; Henry DA
    Med J Aust; 1991 Nov; 155(10):670-4. PubMed ID: 1943895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we aggressive enough in lowering cholesterol?
    Waters DD
    Am J Cardiol; 2001 Aug; 88(4A):10F-5F. PubMed ID: 11520481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient empowerment in secondary prevention of coronary heart disease.
    Holt N; Johnson A; de Belder M
    Lancet; 2000 Jul; 356(9226):314. PubMed ID: 11071193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.